US › Healthcare

Tevogen Bio Holdings Inc. (TVGN)

US · Healthcare · Biotechnology

$7.00-0.28%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-5.4M
Profit YoY
+47.5%
EPS
$-1.61

Key statistics

Market cap
$29.7M
Forward P/E
0.0
P/B
0.00
Book value
$-4.47
EPS (TTM)
$-6.44
52-week high
$70.00
52-week low
$3.64
50-day MA
$7.49
200-day MA
$13.47
Beta
0.22

Analyst view

Analysts rate Tevogen Bio Holdings Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders
79.54%
Institutions
3.24%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC0.79%
BlackRock Inc0.58%
Morgan Stanley - Brokerage Accounts0.41%
Geode Capital Management, LLC0.37%
Deutsche Bank AG0.36%
FMR Inc0.24%
Vanguard Portfolio Management, LLC0.11%
UBS Group AG0.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tevogen Bio Holdings Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.